Final-Program-ATS-2023-AP.vp

306

WEDNESDAY • MAY 24

Chairing: M. Hua, MD, MS, New York, NY

8:10 Screening and Detection of COPD

C.L. Auriemma, MD, Philadelphia, PA N. Khandelwal, MD, MS, Seattle, WA 8:00 Is It the Forest or the Trees: Prioritizing Short Versus Long-Term Outcomes After Critical Illness C.E. Cox, MD, MPH, MHA, Durham, NC 8:13 “She Just Needs More Rehab:” When and Why Aggressive Rehabilitation May Not Be Enough J. Falvey, PhD, DPT, PT, Baltimore, MD 8:26 Money Matters: Is Financial Hardship a Missing Key Outcome in Post-Critical Illness Studies? N. Khandelwal, MD, MS, Seattle, WA 8:39 Psychological Outcomes After Critical Illness: Is the Die Already Cast? W. Lichtenthal, PhD, New York, NY 8:52 To Consult or Not to Consult?: Why Palliative Care May or May Not Change Outcomes in Critically Ill Patients D.B. White, MD, Pittsburgh, PA 9:05 The Glass is Half?: Prognosticating Long-Term Outcomes A. Law, MD, MSci, Boston, MA 9:18 A Bump or a Fork in the Road: the Broader Impact of Critical Illness T.J. Iwashyna, MD, PhD, Baltimore, MD REVISITING BEST BUY INTERVENTIONS FOR THE DIAGNOSIS AND MANAGEMENT OF CHRONIC RESPIRATORY DISEASES IN LOW- AND MIDDLE-INCOME COUNTRIES Assemblies on Clinical Problems; International Health Committee 8:00 AM - 9:30 AM Walter E. Washington Convention Center Room 147 A-B (Street Level) Target Audience Pulmonary medicine researchers, Clinicians in low- and middle-income countries. Objectives At the conclusion of this session, the participant will be able to: • review evidence and prioritize key risk factors for chronic respiratory diseases across a diverse range of LMICs. • identify chronic disease management strategies with greatest potential impact, feasibility, and sustainability in LMICs, i.e., best buy interventions. CLINICAL SCIENTIFIC SYMPOSIUM CME Credits Available: 1.5 D5

R. Vliegenthart, MD, EBCR, FNASCI, FICIS, Groningen, Netherlands

8:30 Heterogeneity of Ventilation in COPD I. Barjaktarevic, MD, PhD, Los Angeles, CA 8:50 Imaging for Bronchoscopic Lung Volume Reduction Valve Targeting M.G. Lester, MD, Nashville, TN 9:10 Panel Discussion and Closing Remarks S.P. Bhatt, MD, MSPH, Birmingham, AL This session and the International Conference are supported by an independent medical educational grant from AstraZeneca LP. All CME sessions have been planned and implemented in accordance with the Accreditation Criteria of the Accreditation Council for Continuing Medical Education (ACCME®) and are free of the control of ineligible companies (formerly commercial interests).

CLINICAL CRITICAL CARE TRACK CME Credits Available: 1.5

D4 THE LONG AND WINDING ROAD: THE FUTURE OF ICU OUTCOMES RESEARCH Assemblies on Critical Care; Behavioral Science and Health

Services Research 8:00 AM - 9:30 AM

Marriott Marquis Washington Independence Ballroom Salons A-D (Level M4)

Target Audience Early Career Professionals, Clinicians, Interprofessionals, Nurses Objectives At the conclusion of this session, the participant will be able to: • to summarize the latest research on long-term outcomes after critical illness, including describing newly recognized key domains of survivorship • to examine the evidence for interventions aimed at improving long-term outcomes in ICU patients and explore barriers to their success • to understand the strengths and limitations of commonly used measures to assess the long-term impact of ICU interventions We aim to provide an update on the latest evidence and persistent challenges surrounding the field of improving long-term outcomes in critically ill patients. In recent years, trials aimed at improving long-term outcomes have largely been unsuccessful, suggesting that it may be time for a critical re-examination and “reboot” of our current conceptual models. In this session, speakers will discuss the current evidence base, lessons learned, implications for current practice, and crucial next steps to advance the field forward.

ATS 2023 • Washington, DC